Kayleigh Watts, from Addenbrooke’s Hospital in Cambridge has worked with people with frontotemporal dementia (FTD) and their loved ones during the Covid-19 pandemic. She reflects on the impact of COVID-19 on those with FTD, in a piece originally written for the Psychologist Magazine.
It’s clear from speaking to our passionate supporters, that they want to see a life-changing new treatment for dementia. Current treatments can help with symptoms for a time, but today there are no medicines to slow down, prevent or treat the underlying diseases that cause dementia.
Although the US and UK health systems are inherently different, this review of the American system is a reminder of the need within our own health system to prepare for new treatments.
This month Emerald Publishing publishes a special issue of the Journal of Public Mental Health entitled “Dementia: a Public Health Priority”.
Drug development takes time, and at Alzheimer’s Research UK we’ve been calling for policy change to help deliver breakthroughs for dementia treatment.
I completed an Open University module in Dementia Care this year and I decided to face the condition head on. I am based in Exeter and on a personal mission to raise dementia awareness in any and every way I can.
Alzheimer’s Research UK held fringe events at the recent party conferences, launching our new manifesto The power to Defeat Dementia.
Baber Malik blogs about the effects dementia has on ethnic minorities in the UK.